"A lively, exciting, and definitely thought-provoking book.” —Booklist Things looked grim for American energy in 2006, but a handful of wildcatters were determined to tap massive deposits of oil and gas that giants like Exxon and Chevron...

'Thrilling, inspiring and informative page-turner.' Walter Isaacson, author of The Code BreakerYou know what went wrong.This is the untold story of what went right.Few were ready when a mysterious respiratory illness emerged in Wuhan,...

This is a new title to be published by Portfolio, an imprint of Penguin Random House. von Zuckerman, Gregory

In "Eine Dosis Hoffnung: Ein Wettlauf auf Leben und Tod – Die wahre Geschichte der Covid-19-Impfstoffe" erzählt Autor Gregory Zuckerman die spannende und dramatische Geschichte der Entwicklung der Covid-19-Impfstoffe. Er gibt einen...

NEW YORK TIMES AND SUNDAY TIMES BUSINESS BESTSELLER SHORTLISTED FOR THE FT AND MCKINSEY BUSINESS BOOK OF THE YEAR AWARD 2019'Reads more like a delicious page-turning novel...Put it on your holiday gift list for your favourite hedge-fund...

NEW YORK TIMES BESTSELLERShortlisted for the Financial Times/McKinsey Business Book of the Year AwardThe unbelievable story of a secretive mathematician who pioneered the era of the algorithm--and made $23 billion doing it.Jim Simons is...

SHORTLISTED FOR THE FT AND MCKINSEY BUSINESS BOOK OF THE YEAR AWARD 2019NEW YORK TIMES AND SUNDAY TIMES BUSINESS BESTSELLER 'Reads more like a delicious page-turning novel...Put it on your holiday gift list for your favourite hedge-fund...

NEW YORK TIMES BESTSELLER Shortlisted for the Financial Times/McKinsey Business Book of the Year Award The unbelievable story of a secretive mathematician who pioneered the era of the algorithm--and made $23 billion doing it. Jim Simons...

Gregory Zuckerman is a special writer at the Wall Street Journal. He writes about big financial trades, hedge funds, private-equity firms and other investing and business topics. He's a three-time winner of the Gerald Loeb Award, the...